Featured Journal Content
Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
European Medicines Agency
News & Press Releases
– No new digest announcements identified
European Centre for Disease Prevention and Control
EASA/ECDC update air travel guidelines to factor in vaccination and latest scientific evidence
Press release – 17 Jun 2021
ECDC and The European Union Aviation Safety Agency (EASA) today issued a new version of the Aviation Health Safety Protocol providing clear operational guidance and risk-based recommendations for health-safe air travel to complement the European Union’s initiatives, such as the EU Digital COVID Certificates.
The new version of the document takes into account new evidence and information such as the circulation of variants of concern (VOCs) and the rollout of the COVID-19 vaccination programmes. The new version also emphasises the need to keep non-pharmaceutical measures in place – such as the wearing of medical face masks, hygiene measures and physical distancing. It is intended to provide support to national authorities in the Member States and to aviation stakeholders and is based on the latest scientific evidence, epidemiological situation and policy developments.
“We have reached a significant milestone in the pandemic: a real change in approach that can allow travellers to fly again without worrying excessively that the rules may change at short notice, complicating their journey or making it impossible,” said EASA Executive Director Patrick Ky. “The industry – and passengers – have been waiting for this moment for a long time. Thanks to the expert epidemiological input from ECDC we are confident that this protocol offers practical and pragmatic guidelines for health-safe travel.”…
ECDC supports EU/EEA Member States in rapid detection of SARS-CoV-2 variants
News story – 16 Jun 2021
ECDC begins epidemic monitoring of the EURO 2020/2021 Football Championship
News story – 15 Jun 2021
Press release 18 June 2021
Belgian Court orders AstraZeneca to deliver vaccine doses to the EU
Today, the Court of First Instance of Brussels decided to grant interim measures in the case brought against AstraZeneca by the European Commission and the 27 EU Member States.
The court orders AstraZeneca to urgently deliver 50 million doses of vaccine by 27 September 2021 – according to a binding schedule:
:: 15 million doses by 26 July, at 9 a.m.,
:: 20 million doses by 23 August,
:: 15 million doses at 27 September.
In the event of non-compliance with these delivery deadlines AstraZeneca will have to pay a penalty of €10 per dose not delivered.
The judge’s decision on the requested interim measures is based on the fact, that AstraZeneca committed a serious breach (‘faute lourde’) of its contractual obligations with the EU.
The court also holds that AstraZeneca should have deployed all its efforts to deliver the vaccines within the agreed timetable including the British production sites explicitly mentioned in the contract – especially given the big delays in deliveries to the EU.
The President of the European Commission, Ursula von der Leyen, welcomes the decision. “This decision confirms the position of the Commission: AstraZeneca did not live up to the commitments it made in the contract. It is good to see that an independent judge confirms this”, President von der Leyen says. “This shows that our European vaccination campaign not only delivers for our citizens day by day. It also demonstrates, that it was founded on a sound legal basis.”
Statement 14 June 2021
EU clears way for the EU Digital COVID Certificate
Today, the Presidents of the three EU institutions, the European Parliament, the Council of the EU and the European Commission attended the official signing ceremony for the Regulation on the EU Digital COVID Certificate, marking the end of the legislative process.